GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
USA - NASDAQ:GDRX - US38246G1085 - Common Stock
3.83 USD
-0.07 (-1.79%)
3.86 USD
+0.03 (+0.78%)
We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make GDRX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
GDRX has a better Return On Assets (2.62%) than 91.43% of its industry peers.
The Return On Equity of GDRX (5.38%) is better than 91.43% of its industry peers.
The Return On Invested Capital of GDRX (5.90%) is better than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROIC | 5.9% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 4.33%, GDRX belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of GDRX has declined.
GDRX has a Operating Margin of 11.10%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
GDRX has a Gross Margin of 93.68%. This is amongst the best in the industry. GDRX outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
The debt/assets ratio for GDRX has been reduced compared to a year ago.
2.2 Solvency
GDRX has an Altman-Z score of 0.89. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX's Altman-Z score of 0.89 is in line compared to the rest of the industry. GDRX outperforms 57.14% of its industry peers.
The Debt to FCF ratio of GDRX is 4.14, which is a neutral value as it means it would take GDRX, 4.14 years of fcf income to pay off all of its debts.
GDRX has a Debt to FCF ratio of 4.14. This is comparable to the rest of the industry: GDRX outperforms 60.00% of its industry peers.
GDRX has a Debt/Equity ratio of 0.75. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, GDRX is doing worse than 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 0.89 |
ROIC/WACC0.53
WACC11.08%
2.3 Liquidity
GDRX has a Current Ratio of 4.21. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GDRX (4.21) is better than 85.71% of its industry peers.
A Quick Ratio of 4.21 indicates that GDRX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.21, GDRX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.67% over the past year.
The earnings per share for GDRX have been decreasing by -24.47% on average. This is quite bad
GDRX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.19%.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
3.2 Future
Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.30% on average per year.
GDRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y15.54%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.94, the valuation of GDRX can be described as very reasonable.
Based on the Price/Earnings ratio, GDRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
GDRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 8.29, which indicates a very decent valuation of GDRX.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
GDRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.94 | ||
| Fwd PE | 8.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 91.43% of the companies listed in the same industry.
GDRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GDRX is cheaper than 91.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.24 | ||
| EV/EBITDA | 9.28 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.99% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3Y16.99%
5. Dividend
5.1 Amount
No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.83
-0.07 (-1.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners58.63%
Inst Owner Change0.6%
Ins Owners11.85%
Ins Owner Change7.93%
Market Cap1.33B
Analysts76.19
Price Target5.43 (41.78%)
Short Float %6.82%
Short Ratio1.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.88%
Min EPS beat(2)-10.65%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-10.65%
Max EPS beat(4)-7.12%
EPS beat(8)3
Avg EPS beat(8)-2.89%
EPS beat(12)7
Avg EPS beat(12)10.95%
EPS beat(16)10
Avg EPS beat(16)12.15%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.55%
Revenue beat(12)1
Avg Revenue beat(12)-1.8%
Revenue beat(16)2
Avg Revenue beat(16)-1.63%
PT rev (1m)0%
PT rev (3m)-15.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.02%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-3.61%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.94 | ||
| Fwd PE | 8.29 | ||
| P/S | 1.66 | ||
| P/FCF | 11.24 | ||
| P/OCF | 6.97 | ||
| P/B | 2.07 | ||
| P/tB | 76.22 | ||
| EV/EBITDA | 9.28 |
EPS(TTM)0.35
EY9.14%
EPS(NY)0.46
Fwd EY12.06%
FCF(TTM)0.34
FCFY8.89%
OCF(TTM)0.55
OCFY14.34%
SpS2.3
BVpS1.85
TBVpS0.05
PEG (NY)0.7
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROCE | 7.47% | ||
| ROIC | 5.9% | ||
| ROICexc | 7.74% | ||
| ROICexgc | 24.97% | ||
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% | ||
| FCFM | 14.8% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | 2.92 | ||
| Cap/Depr | 93.99% | ||
| Cap/Sales | 9.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 115.02% | ||
| Profit Quality | 342.04% | ||
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 0.89 |
F-Score8
WACC11.08%
ROIC/WACC0.53
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y15.54%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
EBIT growth 1Y407.89%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year32.27%
EBIT Next 3Y16.67%
EBIT Next 5Y12.79%
FCF growth 1Y70.28%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y49.36%
OCF growth 3Y0.94%
OCF growth 5Y17.16%